Invenomic Capital Management LP Sells 69,304 Shares of American Vanguard Co. (NYSE:AVD)

Invenomic Capital Management LP lowered its position in American Vanguard Co. (NYSE:AVD - Free Report) by 9.7% during the fourth quarter, according to its most recent filing with the SEC. The firm owned 643,092 shares of the basic materials company's stock after selling 69,304 shares during the period. Invenomic Capital Management LP owned 2.23% of American Vanguard worth $2,978,000 as of its most recent filing with the SEC.

A number of other institutional investors also recently modified their holdings of the company. Topline Capital Management LLC bought a new stake in shares of American Vanguard during the 4th quarter valued at about $3,758,000. CastleKnight Management LP bought a new stake in American Vanguard in the fourth quarter worth approximately $1,368,000. Jacobs Levy Equity Management Inc. lifted its stake in American Vanguard by 63.9% in the fourth quarter. Jacobs Levy Equity Management Inc. now owns 444,574 shares of the basic materials company's stock valued at $2,058,000 after buying an additional 173,349 shares during the period. Cubist Systematic Strategies LLC lifted its stake in American Vanguard by 264.8% in the fourth quarter. Cubist Systematic Strategies LLC now owns 193,846 shares of the basic materials company's stock valued at $898,000 after buying an additional 140,709 shares during the period. Finally, D. E. Shaw & Co. Inc. lifted its stake in American Vanguard by 9.8% in the fourth quarter. D. E. Shaw & Co. Inc. now owns 990,238 shares of the basic materials company's stock valued at $4,585,000 after buying an additional 88,070 shares during the period. 79.04% of the stock is owned by institutional investors.

American Vanguard Trading Down 1.7%

AVD traded down $0.07 during trading on Thursday, hitting $4.11. The company's stock had a trading volume of 296,865 shares, compared to its average volume of 273,980. American Vanguard Co. has a twelve month low of $3.28 and a twelve month high of $9.84. The company has a quick ratio of 0.79, a current ratio of 1.89 and a debt-to-equity ratio of 0.55. The stock's fifty day moving average price is $4.22 and its 200-day moving average price is $4.97. The firm has a market capitalization of $118.32 million, a P/E ratio of -3.99 and a beta of 1.24.

Wall Street Analysts Forecast Growth

Separately, Lake Street Capital set a $14.00 price target on American Vanguard in a research note on Tuesday, January 21st.

American Vanguard Profile

American Vanguard Corporation, through its subsidiaries, develops, manufactures, and markets specialty chemicals for agricultural, commercial, and consumer uses in the United States and internationally. It manufactures and formulates chemicals, including insecticides, fungicides, herbicides, soil health, plant nutrition, molluscicides, growth regulators, soil fumigants, and biorationals in liquid, powder, and granular forms for crops, turf and ornamental plants, and human and animal health protection.